Clinical trial
Ultrasound Biomicroscopy - Apoptosis
NCT00188370 · University Health Network, Toronto, Other · Completed
Key facts
| NCT number | NCT00188370 |
|---|---|
| Title | Ultrasound Biomicroscopy - Apoptosis |
| Official title | Ultrasound Biomicroscopy for Monitoring Apoptosis in Lymphoma, Melanoma and Basal Cell Carcinoma Patients During Chemotherapy or Radiation Therapy |
| Lead sponsor | University Health Network, Toronto, Other |
| Collaborators | Princess Margaret Hospital, Canada |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma, Non-Hodgkin, Melanoma, Carcinoma, Basal Cell |
| Intervention type | Procedure |
| Interventions | high frequency ultrasound imaging |
| Enrollment | 50 |
| Start date | Apr 1, 1999 |
| Completion | Dec 1, 2004 |
| First posted | Sep 16, 2005 |
| Last update posted | Sep 16, 2005 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: